LOKELMA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0310-1110
  • Package NDC 0310-1110-30
  • Package NDC 0310-1110-39
  • Package NDC 0310-1110-93
  • Application number NDA207078
  • SPL ID 7db55610-176b-437e-bcde-4e43d77c49a1
  • SPL set ID 90bf8e28-748d-4e4b-a19f-9cf483370eff
  • UNII D652ZWF066
  • RxCUI 2047633
  • RxCUI 2047639
  • RxCUI 2047642
  • RxCUI 2053927

What the source publishes

Labeler
AstraZeneca Pharmaceuticals LP
Active ingredients
sodium zirconium cyclosilicate
Form
POWDER, FOR SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0310-1110_7db55610-176b-437e-bcde-4e43d77c49a1
{
  "name": "LOKELMA",
  "splId": "7db55610-176b-437e-bcde-4e43d77c49a1",
  "labels": [
    {
      "setId": "90bf8e28-748d-4e4b-a19f-9cf483370eff",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90bf8e28-748d-4e4b-a19f-9cf483370eff",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90bf8e28-748d-4e4b-a19f-9cf483370eff"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AstraZeneca Pharmaceuticals LP",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 PACKET in 1 BOX (0310-1110-30)  / 10 g in 1 PACKET (0310-1110-01)",
      "package_ndc": "0310-1110-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180904"
    },
    {
      "sample": false,
      "description": "11 PACKET in 1 BOX (0310-1110-39)  / 10 g in 1 PACKET (0310-1110-01)",
      "package_ndc": "0310-1110-39",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190102"
    },
    {
      "sample": true,
      "description": "3 PACKET in 1 BOX (0310-1110-93)  / 10 g in 1 PACKET (0310-1110-91)",
      "package_ndc": "0310-1110-93",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240201"
    }
  ],
  "productId": "0310-1110_7db55610-176b-437e-bcde-4e43d77c49a1",
  "useDomain": "unknown",
  "dosageForm": "POWDER, FOR SUSPENSION",
  "productNdc": "0310-1110",
  "deaSchedule": null,
  "genericName": "sodium zirconium cyclosilicate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SODIUM ZIRCONIUM CYCLOSILICATE",
      "strength": "10 g/10g"
    }
  ],
  "applicationNumber": "NDA207078",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180904",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "D652ZWF066"
    ],
    "rxcui": [
      "2047633",
      "2047639",
      "2047642",
      "2053927"
    ],
    "spl_set_id": [
      "90bf8e28-748d-4e4b-a19f-9cf483370eff"
    ],
    "manufacturer_name": [
      "AstraZeneca Pharmaceuticals LP"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0310-1110_7db55610-176b-437e-bcde-4e43d77c49a1"